The @TelAvivUni School of Medicine invited our CEO, Julian Adams, to guest lecture at their “Basic aspects of drug development” program today. Julian will be presenting an overview of Gamida’s scientific platform as a case study, sharing our story from the lab to patients. https://t.co/V7QP1kqLyd